Suchergebnisse - "Cao, Yunlong"

PubPharm (14)

1

Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure

enthalten in: The Lancet. Infectious diseases | 2024

von Yang, S. | Yu, Y. | Xu, Y. | +14

ErratumIn: Lancet Infect Dis. 2024 Jan 3;:. - PMID 38184002

2

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting

enthalten in: Nature | 2024

von Yisimayi, A. | Song, W. | Wang, J. | +23

3

Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers : a randomized, single-blind, placebo-controlled clinical study

enthalten in: Emerging microbes & infections | 2023

von Song, R. | Zeng, G. | Yu, J. | +9

4

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

enthalten in: Nature | 2023

von Cao, Y. | Jian, F. | Wang, J. | +23

5

Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents

enthalten in: Cell reports | 2022

von Cao, Y. | Jian, F. | Zhang, Z. | +27

6

Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants

enthalten in: The Lancet. Infectious diseases | 2022

von Jian, F. | Yu, Y. | Song, W. | +12

7

Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75

enthalten in: Cell host & microbe | 2022

von Cao, Y. | Song, W. | Wang, L. | +28

8

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

enthalten in: Nature | 2022

von Cao, Y. | Yisimayi, A. | Jian, F. | +42

CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1117-1118. - PMID 35777385

9

Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China : a retrospective study

enthalten in: Cell research | 2022

von Zheng, H. | Cao, Y. | Chen, X. | +12

10

Circular RNA vaccines against SARS-CoV-2 and emerging variants

enthalten in: Cell | 2022

von Qu, L. | Yi, Z. | Shen, Y. | +29